Cargando…
Interleukin-32θ Triggers Cellular Senescence and Reduces Sensitivity to Doxorubicin-Mediated Cytotoxicity in MDA-MB-231 Cells
The recently discovered interleukin (IL)- 32 isoform IL-32θ exerts anti-metastatic effects in the breast tumor microenvironment. However, the involvement of IL-32θ in breast cancer cell proliferation is not yet fully understood; therefore, the current study aimed to determine how IL-32θ affects canc...
Autores principales: | Pham, Thu-Huyen, Park, Hyo-Min, Kim, Jinju, Hong, Jin-Tae, Yoon, Do-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124300/ https://www.ncbi.nlm.nih.gov/pubmed/34067074 http://dx.doi.org/10.3390/ijms22094974 |
Ejemplares similares
-
Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells
por: Lee, Kyu-Shik, et al.
Publicado: (2020) -
Parthenolide prevents resistance of MDA-MB231 cells to doxorubicin and mitoxantrone: the role of Nrf2
por: Carlisi, Daniela, et al.
Publicado: (2017) -
Hippuric acid nanocomposite enhances doxorubicin and oxaliplatin-induced cytotoxicity in MDA-MB231, MCF-7 and Caco2 cell lines
por: Al Ali, Samer Hasan Hussein, et al.
Publicado: (2013) -
Potential Effects of Chrysin on MDA-MB-231 Cells
por: Hong, Teh Ban, et al.
Publicado: (2010) -
Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer
por: Pham, Thu-Huyen, et al.
Publicado: (2019)